Skip to main content
Log in

Photosensibilisierung durch Methotrexat

Methotrexate-associated photosensitization

  • Kasuistiken
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Methotrexat (MTX) ist in Deutschland neben Fumarsäure-Estern das am häufigsten für die Behandlung der Psoriasis eingesetzte Systemtherapeutikum. Aufgrund synergistischer Effekte erfolgt gelegentlich eine Kombination von MTX mit Lokal- und/oder Phototherapie.

Fallbericht

Wir beschreiben hier den Fall einer protrahierten phototoxischen Dermatitis unter MTX. Neben der akuten Phototoxizität kann es durch MTX zu einer sog. UV-Reaktivierung, einer Reaktivierung einer Radiodermatitis und der Entstehung von Hauttumoren kommen.

Abstract

Background

Methotrexate (MTX), alongside fumaric acid esters, is the most commonly used drug in the systemic therapy of psoriasis in Germany. It is sometimes used in combination with topical therapy and/or phototherapy due to synergistic effects.

Case report

Here we describe a case of phototoxic dermatitis during treatment with MTX. Other cutaneous side effects of MTX include so-called UV recall, radiation recall, and skin tumor formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Devore KJ (2010) Solar burn reactivation induced by methotrexate. Pharmacotherapy 30:123e–126e

  2. Domm S, Mrowietz U (2011) Combination therapy in the treatment of psoriasis. J Dtsch Dermatol Ges 9:94–98

  3. Goldfeder KL, Levin JM, Katz KA et al (2007) Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy. J Am Acad Dermatol 56:494–499

    Article  PubMed  Google Scholar 

  4. Hirakawa K, Aoshima M, Hiraku Y et al (2002) Photohydrolysis of methotrexate produces pteridine, which induces poly-G-specific DNA damage through photoinduced electron transfer. Photochem Photobiol 76:467–472

    Article  CAS  PubMed  Google Scholar 

  5. Nast A, Boehncke WH, Mrowietz U et al (2011) S3-guidelines for the treatment of psoriasis vulgaris. Update 2011. J Dtsch Dermatol Ges 9(Suppl 2):S1–S104

  6. Nigen S, Knowles SR, Shear NH (2003) Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2:278–299

    PubMed  Google Scholar 

  7. Okamoto H, Fukuda A, Mizuno K et al (1994) Reactivation of phototoxicity test for psoralens plus ultraviolet A by low-dose methotrexate. Photodermatol Photoimmunol Photomed 10:134–136

    CAS  PubMed  Google Scholar 

  8. Pathirana D, Ormerod AD, Saiag P et al (2009) European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23(Suppl 2):1–70

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Hoffmann.

Ethics declarations

Interessenkonflikt

K. Hoffmann, F. Casetti und C. Schempp geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoffmann, K., Casetti, F. & Schempp, C. Photosensibilisierung durch Methotrexat. Hautarzt 66, 459–461 (2015). https://doi.org/10.1007/s00105-014-3569-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-014-3569-6

Schlüsselwörter

Keywords

Navigation